A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations.
Saved in:
| Title: | A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations. |
|---|---|
| Authors: | Roche, Michael1,2, Salimi, Hamid1,3, Duncan, Renee1, Wilkinson, Brendan L.4, Chikere, Kelechi5, Moore, Miranda S.1,6, Webb, Nicholas E.5, Zappi, Helena1,7, Sterjovski, Jasminka1, Flynn, Jacqueline K.1,2, Ellett, Anne1, Gray, Lachlan R.1,8, Lee, Benhur5, Jubb, Becky9, Westby, Mike9, Ramsland, Paul A.10,11,12, Lewin, Sharon R.1,2,13, Payne, Richard J.4, Churchill, Melissa J.1,3,14, Gorry, Paul R.1,2,7 gorry@burnet.edu.au |
| Source: | Retrovirology. 2013, Vol. 10 Issue 1, p1-20. 20p. 2 Diagrams, 3 Charts, 8 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
